Feb 26, 2020 by Amar KhatriHere's Why Karyopharm Therapeutics Has a Unique Growth OpportunityThis cancer-drug maker has a novel medicine with the possibility for extraordinary growth.
Feb 26, 2020 by Amar KhatriBioMarin's Novel Treatment Promises to Disrupt CompetitorsThe gene therapy maker's novel medicine has the potential to take over a highly competitive market and offer growth opportunities for investors.
Feb 20, 2020 by Amar KhatriThe Growth Opportunity That Will Move Medtronic Ahead of Its RivalsOne key division offers strong demand and a solid long-term opportunity for investors.
Feb 12, 2020 by Amar KhatriGilead Sciences Looks Ready to Outpace AbbVieWhich biopharmaceutical company is a better long-term value?
Feb 11, 2020 by Amar KhatriStorage Wars: Where Does Western Digital Stack Up Against Its Rivals?Data storage giant Western Digital competes in a highly competitive space; does it still have a hot hand in the new decade?
Feb 4, 2020 by Amar KhatriIs It Time to Retreat on Qorvo?The radio frequency chipmaker topped earnings expectations, but where is it headed?
Jan 31, 2020 by Amar KhatriAdvanced Micro Devices: Has the Stock Reached Its Peak?The chipmaker narrowly beat Q4 2019 earnings expectations, but uncertainty in 2020 could drive the stock lower.
Jan 30, 2020 by Amar KhatriWill Eli Lilly Outperform in 2020?Recent progress in its drug pipeline and a focus on dealmaking offer strong value for shareholders.
Jan 27, 2020 by Amar KhatriThis Cancer Drug Is Driving Forty Seven's Stock HigherPositive data from a recent study on its lead compound signifies a turning point for the company and could provide further value for investors.
Jan 22, 2020 by Amar KhatriHow Should Investors Approach Exact Sciences in 2020?After a successful 2019, the diagnostics company faces new growth opportunities with both Cologuard and its cancer-diagnostics pipeline.
Jan 22, 2020 by Amar KhatriCan Investors Excel in 2020 With Exelixis?This pharma stock can look forward to a year with more readouts, potential approvals, and new clinical assets providing value in the oncology space.
Jan 18, 2020 by Amar KhatriInvesting in 2020: Should Investors Ride the Wave With Bank of America?An expanding economy, stable interest rates, and the looming U.S. election are key factors when considering this and other banking stocks for the long term.
